A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2001
11/15/2001	CA2407852A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	CA2407850A1 Cytoskeleton-associated proteins
11/15/2001	CA2407830A1 Amino acid derivatives and their use as medicines
11/15/2001	CA2407817A1 Anthranilamides and their use as pharmaceutical agents
11/15/2001	CA2407789A1 Benzoxazines for use in the treatment of parkinson's disease
11/15/2001	CA2407698A1 Repair of nerve damage
11/15/2001	CA2407697A1 Felbamate derived compounds
11/15/2001	CA2406634A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001	CA2406549A1 R-eliprodil for treating glaucoma
11/15/2001	CA2405968A1 Hydantoin derivatives with affinity for somatostatin receptors
11/15/2001	CA2405758A1 Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
11/15/2001	CA2395314A1 Compounds and methods for modulating cerebral amyloid angiopathy
11/14/2001	EP1154019A2 G-protein coupled receptor (HFGAN72X)
11/14/2001	EP1153926A2 3,5-Dioxa-12-aza wurtzitane compound as molecular recognition agent and process of preparing same
11/14/2001	EP1153922A1 Heterodiazinone derivatives
11/14/2001	EP1153603A2 New treatments using phenethylamine derivatives
11/14/2001	EP1153133A2 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same
11/14/2001	EP1153129A1 Method of treating restenosis by antisense targeting of c-myc
11/14/2001	EP1153123A2 Pluripotential cells-2
11/14/2001	EP1153121A2 Secreted proteins and polynucleotides encoding them
11/14/2001	EP1153038A1 Therapeutics and diagnostics based on a il-1b mutation
11/14/2001	EP1153036A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease
11/14/2001	EP1153035A2 Human lipid-associated proteins
11/14/2001	EP1153015A1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases
11/14/2001	EP1153013A2 5-ht1f agonists
11/14/2001	EP1153010A1 $i(N)-SUBSTITUTED AMINO ACIDS, ANTIOXIDANT PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND METHODS USING SAME
11/14/2001	EP1152776A1 Biodegradable, injectable oligomer-polymer composition
11/14/2001	EP1152763A2 Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
11/14/2001	EP1152762A1 Use of desoxypeganine in the treatment of alzheimer's dementia
11/14/2001	EP1152760A1 Use of 4-amino pyridine for treatment of peripheral neuropathies
11/14/2001	EP1152759A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
11/14/2001	EP1152756A1 Anticonvulsant derivatives useful in treating autism
11/14/2001	EP1152751A1 Desoxypeganine transdermal therapeutic system
11/14/2001	EP1152750A1 Spontaneously dispersible n-benzoyl staurosporine compositions
11/14/2001	EP0904081B1 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
11/14/2001	EP0885212B1 Quinoxalinediones
11/14/2001	EP0763037B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
11/14/2001	EP0672041B1 Pharmacologically active pyridine derivatives and processes for the preparation thereof
11/14/2001	CN1322212A Neuropeptide Y agaonists
11/14/2001	CN1322197A New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same
11/14/2001	CN1322196A Naphthalenecaarboxamides as tachykinin receptor antagonists
11/14/2001	CN1322193A Unsaturated hydroximic acid derivatives as PARP inhibitors
11/14/2001	CN1322143A Gene therapy for cerebrovasclar disorders
11/14/2001	CN1322137A Use of GLP-1 or analogs in treatment of stroke
11/14/2001	CN1322136A Neuroimmunophilins for selective neuronal radioprotection
11/14/2001	CN1322134A Naphthalenecarboxamides as tachykinin receptor antagonists
11/14/2001	CN1321643A Nabufulin polybasic ester derivative and its production method
11/14/2001	CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001	CN1321638A Method for preparing methylsulfonate trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperid-1-yl)-1-propanol
11/14/2001	CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001	CN1321500A Method for preventing and curing diseases by using kakonein preparation
11/14/2001	CN1074766C Alkylaminobenzothiazole and -benzoxazole derivatives
11/14/2001	CN1074764C Benzoxazinone dopamine D4 receptor antagonists
11/13/2001	US6316638 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
11/13/2001	US6316504 Administering r(+)-n-propargyl-1-aminoindan or its salt for therapy of multiple sclerosis
11/13/2001	US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001	US6316502 Administering disulfide derivative of dithiocarbamate compound to bind to iron
11/13/2001	US6316501 Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
11/13/2001	US6316485 1,5-diphenylpyrazole derivatives
11/13/2001	US6316478 IL-8 receptor antagonists
11/13/2001	US6316474 Treatment of pain, schizophrenia, parkinson's disease, stroke and depression
11/13/2001	US6316472 Heterosubstituted pyridine derivatives as PDE 4 inhibitors
11/13/2001	US6316466 Pyrazole derivatives P-38 MAP kinase inhibitors
11/13/2001	US6316464 P38 MAP kinase inhibitors
11/13/2001	US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
11/13/2001	US6316456 Purine derivatives having, in particular, antiproliferative properties, and their biological uses
11/13/2001	US6316451 Heterocyclyl anthracyclinone derivatives
11/13/2001	US6316450 Compounds
11/13/2001	US6316448 Pyrazolo[3,4-d][1,2,3] troazines having anticonvulsant activity and process for their preparation
11/13/2001	US6316439 Galanthamine derivatives as acetylcholinesterase inhibitors
11/13/2001	US6316420 Immunization against multiple sclerosis with administering to subject a naked dna nucleic acid construct encoding a cytokine
11/13/2001	US6316417 Parenteral formulations comprising carbamazepine or its derivatives
11/13/2001	US6316415 Sulfonamide interleukin-1β converting enzyme inhibitors
11/13/2001	US6316269 Methods for screening drugs to predict tardive dyskinesia
11/13/2001	US6316259 Antisense inhibition of glycogen synthase kinase 3 alpha expression
11/13/2001	US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/13/2001	US6316027 Fast-dissolving dosage forms for dopamine agonists
11/13/2001	US6316025 Absorption upon digestion
11/13/2001	US6316022 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
11/13/2001	US6315756 Tumescent solution
11/08/2001	WO2001083782A2 Novel proteases
11/08/2001	WO2001083775A2 Proteases
11/08/2001	WO2001083749A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	WO2001083747A2 Prion proteins and their uses
11/08/2001	WO2001083715A2 Derivation of midbrain dopaminergic neurons from embryonic stem cells
11/08/2001	WO2001083560A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	WO2001083555A2 Pain signaling molecules
11/08/2001	WO2001083554A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083552A2 Human sez6 nucleic acids and polypeptides
11/08/2001	WO2001083547A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083543A1 Human wingless-like gene
11/08/2001	WO2001083524A2 Rna metabolism proteins
11/08/2001	WO2001083516A1 Laminin 15 and uses thereof
11/08/2001	WO2001083489A1 THIENO[2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS
11/08/2001	WO2001083486A1 Tricyclic fused pyridine and pyrimidine derivatives as crf receptor antagonists
11/08/2001	WO2001083484A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/08/2001	WO2001083483A1 (5R)-(METHYLAMINO)-5,6-DIHYDRO-4H-IMIDAZO[4,5,1-ij]QUINOLINE-2(1H)-THIONE
11/08/2001	WO2001083475A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001	WO2001083472A1 Muscarinic agonists
11/08/2001	WO2001083462A1 Novel, slow-acting betamimetics, a method for their production and their use as medicaments

1 ... 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 ... 1833